Skip to main content

Table 3 Differences in patients recruited to different study types

From: Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis

    

Percentage of ethnic origin

Studies

Percentage with WHO class III

Percentage with WHO class IV

Percentage with WHO class V

White

Black

Hispanic

Other

Randomised trials

12

78

10

9

35

19

38

Cohort of lupus nephritis

7

64

29

24

11

1

63

Cohort of SLE

Not appropriate

59

29

0

12

  1. SLE, systemic lupus erythematosus; WHO, World Health Organization.